NSE
Amrutanjan Health Care LimitedAMRUTANJAN
Amrutanjan Health Care Limited is an Indian pharmaceutical company focused on the manufacturing and distribution of healthcare products.
| Key products | Pharmaceuticals, Ayurvedic medicines |
|---|---|
| Geography | India (domestic market) |
| Competitors | Dr Reddy's Laboratories, Cadila Healthcare |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹28.8 Cr
Institutional buyers
1 in / 2 out
High-impact filings
0 · tilt Neutral
Next corporate action
Interim Dividend - Re 1 Per Share
ex 2026-02-06
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 5 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 6 | AMRUTANJANThis | −₹28.8 Cr | 3 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — AMRUTANJAN day by day
- 2026-06-15Filing Nageswaramma Private Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SShareholding Disclosure
- 2026-06-15Filing Amulya Kamakshi Priya Arikirevula has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) oShareholding Disclosure
- 2026-06-15Filing Ramaa Prabhakar Arikirevula has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Shareholding Disclosure
- 2026-02-06ActionInterim Dividend - Re 1 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Source PDF →
No bulk/block deals for AMRUTANJAN in this window.
News & chatter on AMRUTANJAN
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.